Pilot Program Launches Affordable Options in GLP-1 for Seniors

Pilot program launches affordable options in GLP-1 for seniors

Medicare began a federal pilot program that covers the cost of powerful GLP-one weight-loss drugs, such as Wegovy and Zepbound, for eligible older Americans. This new initiative allows participants to access these medications for $50 a month.

Medicare is now offering $50 GLP-1 prescriptions. The US may never be the same.

The latest breakthrough for GLP-1 drugs isn’t scientific. It’s financial. As of July 1, Medicare is providing coverage of GLP-1 medications for weight loss for just a $50 co-pay, potentially enabling millions more Americans to get onto this much-hyped new class of drugs. Medicare’s GLP-1 Bridge Program, as it is called, is technically a one-year pilot project authorized by the Trump administration. Medicare previously limited GLP-1 coverage to p…

Medicare now covers GLP-1 weight loss drugs for eligible beneficiaries

Medicare is covering GLP-1 weight loss medication for the first time for many older adults.

IN GOOD HEALTH: Medicare Now Covering GLP-1 Drugs for Weight Loss – GLP-1 Bridge Program Short-term ‘Demonstration’

By Leanna Coy, FNP BC In 2003, Congress made changes to Medicare. The Prescription Drug, Improvement, and Modernization Act barred weight loss medication coverage. This came on the heels of diet pill problems, such as fen-phen, in the 1990s. GLP-1 medications (glucagon-like peptide-1 receptor agonists) are now widely used for weight loss with science-backed benefits. This has prompted the new short-term Medicare GLP-1 Bridge project from the Cen…